Search Results - "Guzman-Becerra, Norma" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN‐LABEL GLOBAL PHASE3 STUDY OF TAB‐CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN‐LABEL GLOBAL PHASE3 STUDY OF TAB‐CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

by Kris Michael, Mahadeo, Robert, Baiocchi, Amer, Beitinjaneh, Sridhar, Chaganti, Choquet, Sylvain, Dierickx, Daan, Rajani, Dinavahi, Gamelin, Laurence, Ghobadi, Armin, Norma, Guzman‐Becerra, Manher, Joshi, Aditi, Mehta, Sarah, Nikiforow, Ran, Reshef, Wei, Ye, Susan, Prockop
Published in HemaSphere (08.08.2023)

Get full text

Journal Article

Characteristics of Malt Liquor Beer Drinkers in a Low-Income, Racial Minority Community Sample

Characteristics of Malt Liquor Beer Drinkers in a Low-Income, Racial Minority Community Sample

by Bluthenthal, Ricky N., BrownTaylor, Didra, Guzmán-Becerra, Norma, Robinson, Paul L.
Published in Alcoholism, clinical and experimental research (01.03.2005)

Get full text

Journal Article

A Longitudinal Analysis of Unmet Need for Oral Treatment in a National Sample of Medical HIV Patients

A Longitudinal Analysis of Unmet Need for Oral Treatment in a National Sample of Medical HIV Patients

by Marcus, Marvin, Maida, Carl A, Coulter, Ian D, Freed, James R, Der-Martirosian, Claudia, Liu, Honghu, Freed, Benjamin A, Guzman-Becerra, Norma, Andersen, Ronald M
Published in American journal of public health (1971) (01.01.2005)

Get full text

Journal Article

Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A

Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A

by Auerswald, Guenter, Thompson, Alexis A., Recht, Michael, Brown, Deborah, Liesner, Raina, Guzmán-Becerra, Norma, Dyck-Jones, Jacqueline, Ewenstein, Bruce, Abbuehl, Brigitt
Published in Thrombosis and haemostasis (01.06.2012)

Get full text

Journal Article

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial

by Mahadeo, Kris Michael, Baiocchi, Robert, Beitinjaneh, Amer, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Duan, Xinyuan, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, Manher, Mehta, Aditi, Navarro, Willis H, Nikiforow, Sarah, O'Reilly, Richard J, Reshef, Ran, Ruiz, Fiona, Spindler, Tassja, Prockop, Susan
Published in The lancet oncology (01.03.2024)

Get full text

Journal Article

Exploring the Impact of Humoral Immunogenicity with Tabelecleucel for the Treatment of EBV+ PTLD Following HCT and SOT

Exploring the Impact of Humoral Immunogenicity with Tabelecleucel for the Treatment of EBV+ PTLD Following HCT and SOT

by Spindler, Tassja J, Ruiz, Fiona, Jehng, Tiffany, Ding, Hanna, Guzman-Becerra, Norma, Khanzadeh, Shahram, Li, Xiaoming, Gamelin, Laurence, Dubovsky, Jason A., Nguyen, Cokey
Published in Blood (15.11.2022)

Get full text

Journal Article

Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study

Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study

by Sanz, Jaime, Storek, Jan, Socié, Gérard, Thirumalai, Dhanalakshmi, Guzman-Becerra, Norma, Xun, Pengcheng, Kumar, Deepali, Sadetsky, Natalia, Dierickx, Daan, Reitan, John, Barlev, Arie, Mohty, Mohamad
Published in Blood (23.11.2021)

Get full text

Journal Article

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

by Mahadeo, Kris Michael, Baiocchi, Robert A., Beitinjaneh, Amer, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, Manher, Mehta, Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan
Published in Blood (15.11.2022)

Get full text

Journal Article

Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant

Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant

by Barlev, Arie, Zimmermann, Heiner, Guzman-Becerra, Norma, Mehta, Aditi, Xing, Baodong, Macabeo, Bérengère, Thivolet, Marion, Brookhart, M Alan
Published in Journal of medical economics (01.01.2024)

Get full text

Journal Article

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

by Socié, Gérard, Barba, Pere, Barlev, Arie, Sanz, Jaime, García-Cadenas, Irene, Chevallier, Patrice, Fagioli, Franca, Guzman-Becerra, Norma, Kumar, Deepali, Ljungman, Per, Pigneux, Arnaud, Sadetsky, Natalia, Yáñez San Segundo, Lucrecia, Shadman, Mazyar, Storek, Jan, Thirumalai, Dhanalakshmi, Xing, Baodong, Mohty, Mohamad
Published in Bone marrow transplantation (Basingstoke) (01.01.2024)

Get full text

Journal Article

$Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV+ post-transplant lymphoproliferative disease (PTLD)$

Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV+ post-transplant lymphoproliferative disease (PTLD)

by Aftab, Blake T., Shen, Rhine R., Guzman-Becerra, Norma, Sun, Yan, Forozan, Farahnaz, Prockop, Susan, Doubrovina, Ekaterina, O'Reilly, Richard J., Li, Xiaoming, Hiremath, Minoti, Gamelin, Laurence, Navarro, Willis H.
Published in Journal of clinical oncology (10.02.2020)

Get full text

Journal Article

A Multicenter, Multicohort, Open-Label, Single Arm per Cohort, Phase II Study to Assess the Efficacy and Safety of Tabelecleucel in Patients with EBV-Associated Diseases Using an Adaptive Two-Stage Study Design

A Multicenter, Multicohort, Open-Label, Single Arm per Cohort, Phase II Study to Assess the Efficacy and Safety of Tabelecleucel in Patients with EBV-Associated Diseases Using an Adaptive Two-Stage Study Design

by Prockop, Susan E., Dinavahi, Rajani, Navarro, Willis H., Guzman-Becerra, Norma, Sun, Yan, Gamelin, Laurence
Published in Transplantation and cellular therapy (01.03.2021)

Get full text

Journal Article

200 - Exploring the Impact of Humoral Immunogenicity with Tabelecleucel (Tab-cel) for the Treatment of Epstein–Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Hematopoietic Stem Cell Transplantation (HCT) and Solid Organ Transplantation (SOT)

200 - Exploring the Impact of Humoral Immunogenicity with Tabelecleucel (Tab-cel) for the Treatment of Epstein–Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Hematopoietic Stem Cell Transplantation (HCT) and Solid Organ Transplantation (SOT)

by Spindler, Tassja J., Ruiz, Fiona, Jehng, Tiffany, Ding, Hanna, Guzman-Becerra, Norma, Khanzadeh, Shahram, Li, Xiaoming, Gamelin, Laurence, Dubovsky, Jason, Nguyen, Cokey
Published in Transplantation and cellular therapy (01.02.2023)

Get full text

Journal Article

Exploring the Impact of Humoral Immunogenicity with Tabelecleucel (Tab-cel) for the Treatment of Epstein–Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Hematopoietic Stem Cell Transplantation (HCT) and Solid Organ Transplantation (SOT)

Exploring the Impact of Humoral Immunogenicity with Tabelecleucel (Tab-cel) for the Treatment of Epstein–Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Hematopoietic Stem Cell Transplantation (HCT) and Solid Organ Transplantation (SOT)

by Spindler, Tassja J., Ruiz, Fiona, Jehng, Tiffany, Ding, Hanna, Guzman-Becerra, Norma, Khanzadeh, Shahram, Li, Xiaoming, Gamelin, Laurence, Dubovsky, Jason, Nguyen, Cokey
Published in Transplantation and cellular therapy (01.02.2023)

Get full text

Journal Article

25 - New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)

25 - New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)

by Beitinjaneh, Amer, Baiocchi, Robert, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, AJ, Mahadeo, Kris Michael, Mehta, Dr. Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan
Published in Transplantation and cellular therapy (01.02.2023)

Get full text

Journal Article

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)

by Beitinjaneh, Amer, Baiocchi, Robert, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, AJ, Mahadeo, Kris Michael, Mehta, Dr. Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan
Published in Transplantation and cellular therapy (01.02.2023)

Get full text

Journal Article

Clinical Experience of Tabelecleucel in Patients with Life-Threatening Complications of Epstein–Barr Virus Viremia

Clinical Experience of Tabelecleucel in Patients with Life-Threatening Complications of Epstein–Barr Virus Viremia

by Torno, Lilibeth, Dahlberg, Ann, Ghobadi, Armin, Stiff, Patrick, Reshef, Ran, Weng, Wen-Kai, Navarro, Willis H., Gamelin, Laurence, Dinavahi, Rajani, Sun, Yan, Guzman-Becerra, Norma, Prockop, Susan E.
Published in Transplantation and cellular therapy (01.03.2021)

Get full text

Journal Article

Clinical Experience of Tabelecleucel in Patients with EBV+ Primary (PID) or Acquired Immunodeficiency (AID) Associated Lymphoproliferative Disease

Clinical Experience of Tabelecleucel in Patients with EBV+ Primary (PID) or Acquired Immunodeficiency (AID) Associated Lymphoproliferative Disease

by Nikiforow, Sarah, Baiocchi, Robert, Nasta, Sunita, Weng, Wen-Kai, Loeb, David, Mahadeo, Kris Michael, Whangbo, Jennifer, Phuong, Patrick, Navarro, Willis H., Gamelin, Laurence, Sun, Yan, Guzman-Becerra, Norma, Prockop, Susan E.
Published in Transplantation and cellular therapy (01.03.2021)

Get full text

Journal Article

Oral white patches in a national sample of medical HIV patients in the era of HAART

Oral white patches in a national sample of medical HIV patients in the era of HAART

by Marcus, Marvin, Maida, Carl A., Freed, James R., Younai, Fariba, Coulter, Ian D., Der-Martirosian, Claudia, Liu, Honghu, Freed, Benjamin, Guzmán-Becerra, Norma, Shapiro, Martin
Published in Community dentistry and oral epidemiology (01.04.2005)

Get full text

Journal Article

Safety and Efficacy Profile of rAHF-PFM for Immune Tolerance Induction as Assessed In 3 Clinical Trials (PUP ITI, PRE-PAIR, and PAIR)

by Spotts, Gerald, Abbuehl, Brigitt E., Luu, Huong D., Song, Clara K., Dyck-Jones, Jacqueline A., Guzman-Becerra, Norma, Wu, LieLing, Oh, MyungShin, Zoerer, Michael, Sosa, Judith Jill V., Stephens, Darby E., Yamamoto, Linda J., Ewenstein, Bruce M.
Published in Blood (19.11.2010)

Get full text

Journal Article